Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Machaon who wrote (20721)	5/13/1998 11:23:00 PM
From: Andrew H	Read Replies (2) \| Respond to of 32384

>>I have made about 6 bad predictions in a row, but....... I think that LGND's stock might jump up quite a bit on the NDA filing for Panretin Topical.<< 100 more and you'll be getting close to tonyt and Fugazi! I agree the stock could jump on the Panretin filing. If not, it could be a long dry spell. It's the first topical ointment treatment for cancer! Even though they are only getting approval for KS, to me, it has much greater possibilities. Plus, if it is hyped correctly, the public might react. As Herbert pointed out, what's important is its effect on mice!!